Literature DB >> 18450822

Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells.

Hidetoshi Sakurai1, Yayoi Okawa, Yuta Inami, Naomi Nishio, Ken-ichi Isobe.   

Abstract

Pluripotent embryonic stem (ES) cells hold great potential for cell-based therapies. Although several recent studies have reported the potential of ES cell-derived progenitors for skeletal muscle regeneration, how the cells contribute to reconstitution of the damaged myofibers has remained elusive. Here, we demonstrated the process of injured muscle regeneration by the engraftment of ES cell-derived mesodermal progenitors. Mesodermal progenitor cells were induced by a conventional differentiation system and isolated by flow cytometer of platelet-derived growth factor receptor-alpha (PDGFR-alpha), a marker of paraxial mesoderm, and vascular endothelial growth factor receptor-2 (VEGFR-2), a marker of lateral mesoderm. The PDGFR-alpha(+) population that represented the paraxial mesodermal character demonstrated significant engraftment when transplanted into the injured muscle of immunodeficient mouse. Moreover, the PDGFR-alpha(+) population could differentiate into the muscle satellite cells that were the stem cells of adult muscle and characterized by the expression of Pax7 and CD34. These ES cell-derived satellite cells could form functional mature myofibers in vitro and generate myofibers fused with the damaged host myofibers in vivo. On the other hand, the PDGFR-alpha(-)VEGFR-2(+) population that showed lateral mesodermal character exhibited restricted potential to differentiate into the satellite cells in injured muscle. Our results show the potential of ES cell-derived paraxial mesodermal progenitor cells to generate functional muscle stem cells in vivo without inducing or suppressing gene manipulation. This knowledge could be used to form the foundation of the development of stem cell therapies to repair diseased and damaged muscles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450822     DOI: 10.1634/stemcells.2008-0173

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  25 in total

Review 1.  Differentiation of mesodermal cells from pluripotent stem cells.

Authors:  Michinori Kitagawa; Takumi Era
Journal:  Int J Hematol       Date:  2010-03-12       Impact factor: 2.490

2.  DYS-HAC-iPS cells: the combination of gene and cell therapy to treat duchenne muscular dystrophy.

Authors:  In-Hyun Park
Journal:  Mol Ther       Date:  2010-02       Impact factor: 11.454

3.  Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors.

Authors:  Radbod Darabi; Filipe N C Santos; Antonio Filareto; Weihong Pan; Ryan Koene; Michael A Rudnicki; Michael Kyba; Rita C R Perlingeiro
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

Review 4.  Satellite cells and the muscle stem cell niche.

Authors:  Hang Yin; Feodor Price; Michael A Rudnicki
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

5.  Converting pathological cells to therapeutic ones: an odyssey through pluripotency.

Authors:  Jean-Thomas Vilquin
Journal:  Mol Ther       Date:  2012-11       Impact factor: 11.454

Review 6.  Coaxing stem cells for skeletal muscle repair.

Authors:  Karl J A McCullagh; Rita C R Perlingeiro
Journal:  Adv Drug Deliv Rev       Date:  2014-07-15       Impact factor: 15.470

7.  Five transcriptional factors reprogram fibroblast into myogenic lineage cells via paraxial mesoderm stage.

Authors:  Meeyul Hwang; Eun-Joo Lee; Myung-Jin Chung; SunYoung Park; Kyu-Shik Jeong
Journal:  Cell Cycle       Date:  2020-06-17       Impact factor: 4.534

Review 8.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.

Authors:  Francesco Saverio Tedesco; Arianna Dellavalle; Jordi Diaz-Manera; Graziella Messina; Giulio Cossu
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

Review 9.  Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks.

Authors:  Fabrizio Rinaldi; Rita C R Perlingeiro
Journal:  Transl Res       Date:  2013-11-14       Impact factor: 7.012

Review 10.  Gene and cell-mediated therapies for muscular dystrophy.

Authors:  Patryk Konieczny; Kristy Swiderski; Jeffrey S Chamberlain
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.